1.
Armstrong A, Strober B, Gordon K, Zhuo J, Becker B, Kisa R, Throup J, Kim J, Papp K. Deucravacitinib Improves Psoriasis Symptoms and Signs Diary Domain Scores in Patients With Moderate to Severe Plaque Psoriasis: Results From the Phase 3 POETYK PSO-1 and POETYK PSO-2 Studies. J of Skin [Internet]. 2021Nov.5 [cited 2022Aug.12];5(6):s38. Available from: https://jofskin.org/index.php/skin/article/view/1389